Information Provided By:
Fly News Breaks for July 27, 2016
NUVA
Jul 27, 2016 | 05:54 EDT
Piper Jaffray analyst Matt O'Brien views NuVasive's Q2 results as "impressive" as its operating margin beat elevated Street expectations. To reflect "momentum across the business," the analyst raised his price target for the shares to $70 from $65. He keeps an Overweight rating on NuVasive.
News For NUVA From the Last 2 Days
There are no results for your query NUVA